Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2382041977
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Schulthess, G. K.
Right arrow Articles by Hany, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Schulthess, G. K.
Right arrow Articles by Hany, T. F.
(Radiology 2006;238:405-422.)
© RSNA, 2006


State of the Art

Integrated PET/CT: Current Applications and Future Directions1

Gustav K. von Schulthess, MD, PhD, Hans C. Steinert, MD and Thomas F. Hany, MD

1 From the Department of Nuclear Medicine, University Hospital of Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. Received November 20, 2004; revision requested January 27, 2005; revision received February 21; accepted April 4; final version accepted, May 12; updated August 29. Address correspondence to G.K.v.S.

For the past 5 years, combined positron emission tomography (PET) and computed tomography (CT), or PET/CT, has grown because the PET portion provides information that is very different from that obtainable with other imaging modalities. However, the paucity of anatomic landmarks on PET images makes a consistent "hardware fusion" to anatomic cross-sectional data extremely useful. Clinical experience indicates a single direction: Addition of CT to PET improves specificity foremost, but also sensitivity, and the addition of PET to CT adds sensitivity and specificity in tumor imaging. Thus, PET/CT is a more accurate test than either of its individual components and is probably also better than side-by-side viewing of images from both modalities. The synergistic advantage of adding CT is that the attenuation correction needed for PET can also be derived from the CT data, an advantage not obtainable by integrating PET and magnetic resonance imaging. This makes PET/CT 25%–30% faster than PET alone with standard attenuation-correction methods, leading to higher patient throughput and a more comfortable examination, which typically last 30 minutes or less. Fluorodeoxyglucose (FDG) PET/CT appears to provide relevant information in the staging and therapy monitoring of many tumors, including lung carcinoma, mesothelioma, colorectal cancer, lymphoma, melanoma, and many others, with the notable exception of prostatic cancer. For prostatic cancer, choline derivatives may become useful radiopharmaceuticals. The published literature on the applications of FDG PET/CT in oncology is still limited, but several well-designed studies have demonstrated the benefits of PET/CT.

© RSNA, 2006




This article has been cited by other articles:


Home page
ChestHome page
K. Mohan, F. Simeone, and N. Parada
A 79-Year-Old Man With Chest Wall Pain and a Rapidly Growing Mass
Chest, January 1, 2009; 135(1): 221 - 224.
[Full Text] [PDF]


Home page
RadiologyHome page
B. Krug, R. Crott, M. Lonneux, J.-F. Baurain, A.-S. Pirson, and T. Vander Borght
Role of PET in the Initial Staging of Cutaneous Malignant Melanoma: Systematic Review
Radiology, December 1, 2008; 249(3): 836 - 844.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. E. Hillner, B. A. Siegel, A. F. Shields, D. Liu, I. F. Gareen, E. Hunt, and R. E. Coleman
Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry
J. Nucl. Med., December 1, 2008; 49(12): 1928 - 1935.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W. Luboldt, R. Kufer, N. Blumstein, T. L. Toussaint, A. Kluge, M. D. Seemann, and H.-J. Luboldt
Prostate Carcinoma: Diffusion-weighted Imaging as Potential Alternative to Conventional MR and 11C-Choline PET/CT for Detection of Bone Metastases
Radiology, December 1, 2008; 249(3): 1017 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. B. Sorensen, J. Ravn, A. Loft, J. Brenoe, A. K. Berthelsen, and on behalf of the Nordic Mesothelioma Group
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy
Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1090 - 1096.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. H. Kushner, M. P. Laquaglia, W. L. Gerald, K. Kramer, S. Modak, and N.-K. V. Cheung
Solitary Relapse of Desmoplastic Small Round Cell Tumor Detected by Positron Emission Tomography/Computed Tomography
J. Clin. Oncol., October 20, 2008; 26(30): 4995 - 4996.
[Full Text] [PDF]


Home page
JNMHome page
A. K. Buck, S. Nekolla, S. Ziegler, A. Beer, B. J. Krause, K. Herrmann, K. Scheidhauer, H.-J. Wester, E. J. Rummeny, M. Schwaiger, et al.
SPECT/CT
J. Nucl. Med., August 1, 2008; 49(8): 1305 - 1319.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Plathow and W. A. Weber
Tumor Cell Metabolism Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. K. Buck, K. Herrmann, C. M. z. Buschenfelde, M. E. Juweid, M. Bischoff, G. Glatting, G. Weirich, P. Moller, H.-J. Wester, K. Scheidhauer, et al.
Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
Clin. Cancer Res., May 15, 2008; 14(10): 2970 - 2977.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. E. Hillner, B. A. Siegel, D. Liu, A. F. Shields, I. F. Gareen, L. Hanna, S. H. Stine, and R. E. Coleman
Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry
J. Clin. Oncol., May 1, 2008; 26(13): 2155 - 2161.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. C. Kwee, R. M. Kwee, and R. A. J. Nievelstein
Imaging in staging of malignant lymphoma: a systematic review
Blood, January 15, 2008; 111(2): 504 - 516.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Tatsumi, J. H. Miller, and R. L. Wahl
18F-FDG PET/CT in Evaluating Non-CNS Pediatric Malignancies
J. Nucl. Med., December 1, 2007; 48(12): 1923 - 1931.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. U. Gerth, K. U. Juergens, U. Dirksen, J. Gerss, O. Schober, and C. Franzius
Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors
J. Nucl. Med., December 1, 2007; 48(12): 1932 - 1939.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Y. Du, I. Cullum, T. M. Illidge, and P. J. Ell
Fusion of Metabolic Function and Morphology: Sequential [18F]Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Studies Yield New Insights Into the Natural History of Bone Metastases in Breast Cancer
J. Clin. Oncol., August 10, 2007; 25(23): 3440 - 3447.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. S.P. Meirelles, Y. E. Erdi, S. A. Nehmeh, O. D. Squire, S. M. Larson, J. L. Humm, and H. Schoder
Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions
J. Nucl. Med., May 1, 2007; 48(5): 712 - 719.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Nahmias, W. T. Hanna, L. M. Wahl, M. J. Long, K. F. Hubner, and D. W. Townsend
Time Course of Early Response to Chemotherapy in Non-Small Cell Lung Cancer Patients with 18F-FDG PET/CT
J. Nucl. Med., May 1, 2007; 48(5): 744 - 751.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Lindsay, B. A. Siegel, S. R. Tunis, B. E. Hillner, A. F. Shields, B. P. Carey, and R. E. Coleman
The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence Development
Am. J. Roentgenol., April 1, 2007; 188(4): 1109 - 1113.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang
Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1
J. Nucl. Med., February 1, 2007; 48(2): 227 - 233.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Even-Sapir, G. Flusser, H. Lerman, G. Lievshitz, and U. Metser
SPECT/Multislice Low-Dose CT: A Clinically Relevant Constituent in the Imaging Algorithm of Nononcologic Patients Referred for Bone Scintigraphy
J. Nucl. Med., February 1, 2007; 48(2): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. H. O, I. R. Yoo, S. H. Kim, H. S. Sohn, and S. K. Chung
Clinical Significance of Small Pulmonary Nodules with Little or No 18F-FDG Uptake on PET/CT Images of Patients with Nonthoracic Malignancies
J. Nucl. Med., January 1, 2007; 48(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. D. Berry and G. J. R. Cook
Positron emission tomography in oncology
Br. Med. Bull., December 14, 2006; (2006) ldl013v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2006 by the Radiological Society of North America.